<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="625">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05153018</url>
  </required_header>
  <id_info>
    <org_study_id>2020-100</org_study_id>
    <nct_id>NCT05153018</nct_id>
  </id_info>
  <brief_title>Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu</brief_title>
  <acronym>PIANO</acronym>
  <official_title>Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Pasteur</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health of Vanuatu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vanuatu National Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut Pasteur</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Pacific region is facing several emerging and neglected diseases notably mosquito-borne&#xD;
      diseases as malaria or arboviroses among which dengue, Ross River, chikungunya and Zika.&#xD;
      These diseases are an important cause of illness and death in the Pacific and the occurrence&#xD;
      of arboviruses has increased in the recent years. In humans, these mosquito-borne diseases&#xD;
      often have very similar clinical presentations (an acute febrile syndrome often&#xD;
      self-limiting). However, these infections can progress to severe and fatal prognosis.&#xD;
&#xD;
      Numerous arboviroses outbreaks and in particular dengue outbreaks have affected Vanuatu for&#xD;
      decades. Except for DENV and Zika for which epidemiological and virological data are&#xD;
      available for Vanuatu, the knowledge on chikungunya and Ross River circulation is very&#xD;
      limited and needs to be defined as both viruses have intensively circulated in the region in&#xD;
      the past. Knowledge of the level of immune protection of the population for these&#xD;
      mosquito-borne diseases is incomplete. For this purpose, seroprevalence studies that intend&#xD;
      to retrospectively look for antibodies (IgG) as an evidence of previous infections by a&#xD;
      specific pathogen would be highly informative. Knowing the serological profile of the Vanuatu&#xD;
      population for dengue and other arboviruses as Ross River, chikungunya and Zika that could&#xD;
      have affected the country in the past would be useful in defining the population likely to be&#xD;
      infected by future epidemics.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The PIANO project is a non-comparative observational prospective cross-sectional descriptive&#xD;
      survey on a representative random sample of the population.&#xD;
&#xD;
      The study will be conducted on a 4-mL blood sample collected in a dry tube from 1,200&#xD;
      non-febrile individuals aged older than 6 years old.&#xD;
&#xD;
      The main objective of the current project is to determine the seroprevalence of dengue, Zika,&#xD;
      chikungunya and Ross River in Vanuatu.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 15, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determination of the seroprevalence of dengue, Zika, chikungunya and Ross River in Vanuatu.</measure>
    <time_frame>1 year</time_frame>
    <description>Exploration of vector-borne diseases seroprevalence in the main Provinces usually involved in outbreaks, the study will be implemented in the main cities of Efate, Santo, Tanna and Malekula Islands namely Port Vila, Luganville, Isangel and Lakatoro along with rural parts connected to the main city by main roads.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Arbovirus Disease</condition>
  <condition>Zika</condition>
  <condition>Dengue</condition>
  <condition>Ross River</condition>
  <condition>Chikungunya</condition>
  <arm_group>
    <arm_group_label>A representative random sample of the population</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>1,200 non-febrile individuals aged older than 6 years old</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood collection</intervention_name>
    <description>a 4-mL blood sample collected in a dry tube</description>
    <arm_group_label>A representative random sample of the population</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Individuals informed of the research and having given their written consent to&#xD;
             participate in the study&#xD;
&#xD;
          -  Individuals aged 6 years old or more&#xD;
&#xD;
          -  Individuals living in Vanuatu for more than 6 months&#xD;
&#xD;
          -  Individuals informed of the research, its objectives and procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Tourists and people present in Vanuatu for less than 6 months&#xD;
&#xD;
          -  Persons intellectually disabled or under guardianship&#xD;
&#xD;
          -  Persons suffering from a febrile syndrome&#xD;
&#xD;
          -  Missing information related to age or hometown&#xD;
&#xD;
          -  Children weighting less than 18 kg&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Myrielle Dupont-Rouzeyrol, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Institut Pasteur de Nouvelle-Cal√©donie</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Myrielle Dupont-Rouzeyrol, Ph</last_name>
    <phone>+687 27 75 30</phone>
    <email>mdupont@pasteur.nc</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Catherine Inizan, PhD</last_name>
    <phone>+687 27 26 66</phone>
    <email>cinizan@pasteur.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Blood centers, hospitals, health facilities</name>
      <address>
        <city>Luganville</city>
        <country>Vanuatu</country>
      </address>
    </facility>
    <contact>
      <last_name>Roger Jimmy, MD</last_name>
      <email>rojimmy@vanuatu.gov.vu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schools</name>
      <address>
        <city>Luganville</city>
        <country>Vanuatu</country>
      </address>
    </facility>
    <contact>
      <last_name>Roger Jimmy, MD</last_name>
      <email>rojimmy@vanuatu.gov.vu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Blood centers, hospitals, health facilities</name>
      <address>
        <city>Port-Vila</city>
        <country>Vanuatu</country>
      </address>
    </facility>
    <contact>
      <last_name>Wesley Donald, MD</last_name>
      <email>wdonald@vanuatu.gov.vu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schools</name>
      <address>
        <city>Port-Vila</city>
        <country>Vanuatu</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Vanuatu</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>November 29, 2021</study_first_submitted>
  <study_first_submitted_qc>November 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2021</study_first_posted>
  <last_update_submitted>November 29, 2021</last_update_submitted>
  <last_update_submitted_qc>November 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Serology</keyword>
  <keyword>Epidemiology</keyword>
  <keyword>Vanuatu</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vector Borne Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

